BOSTON — The Federal Emergency Management Agency will be sending more than $6.5 million to the Commonwealth of Massachusetts to reimburse it for the cost of providing monoclonal antibody treatment services to the public during the COVID-19 pandemic.

 

The $6,516,938 Public Assistance grant will reimburse the Massachusetts Department of Public Health for the cost of contracting with Gothams, LLC to provide monoclonal antibody (mAB) infusion treatment and therapy to high-risk COVID-19 patients between July and September 2022.

 

The 1,573 infusion treatments were provided at four locations: Baystate Medical Center Education Center in Holyoke, Athol Hospital, Beth Israel Deaconess Plymouth, and Lowell General Hospital-Saints Campus.

 

"FEMA is pleased to be able to assist Massachusetts with these costs," said FEMA Region 1 Regional Administrator Lori Ehrlich. "Reimbursing state, county, and municipal governments – as well as eligible non-profits and tribal entities – for the costs incurred during the COVID-19 pandemic is an important part of our nation's ongoing recovery."

 

FEMA's Public Assistance program is an essential source of funding for states and communities recovering from a federally declared disaster or emergency.

 

So far, FEMA has provided more than $2.8 billion in Public Assistance grants to Massachusetts to reimburse the commonwealth for pandemic-related expenses.